December 23, 2022
Melanoma Immunotherapy with GPR182 blockade
Description: Immune checkpoint inhibitor therapy has greatly improved survival of patients with late-stage melanoma. However, about 2/3 of patients do not benefit from this...
Check out the #GetNaked Campaign
March 31, 2026
Description: Immune checkpoint inhibitor therapy has greatly improved survival of patients with late-stage melanoma. However, about 2/3 of patients do not benefit from this...
May 02, 2026 PT
May 08, 2026 CT
May 09, 2026 ET
May 12, 2026 ET
May 26, 2026 ET